Your browser is no longer supported. Please, upgrade your browser.
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E20.05 EPS (ttm)2.19 Insider Own0.04% Shs Outstand5.60B Perf Week-3.73%
Market Cap248.45B Forward P/E12.21 EPS next Y3.60 Insider Trans-0.32% Shs Float5.59B Perf Month-10.99%
Income12.40B PEG1.61 EPS next Q1.08 Inst Own67.40% Short Float1.05% Perf Quarter13.09%
Sales55.52B P/S4.48 EPS this Y-33.10% Inst Trans1.30% Short Ratio1.86 Perf Half Y23.53%
Book/sh12.51 P/B3.51 EPS next Y-12.17% ROA8.00% Target Price45.86 Perf Year25.78%
Cash/sh3.83 P/C11.45 EPS next 5Y12.42% ROE19.80% 52W Range32.79 - 51.86 Perf YTD19.23%
Dividend1.56 P/FCF19.77 EPS past 5Y2.20% ROI7.60% 52W High-15.37% Beta0.73
Dividend %3.55% Quick Ratio1.10 Sales past 5Y-3.00% Gross Margin74.70% 52W Low33.85% ATR1.21
Employees78500 Current Ratio1.40 Sales Q/Q92.40% Oper. Margin24.30% RSI (14)36.37 Volatility2.43% 2.32%
OptionableYes Debt/Eq0.56 EPS Q/Q111.20% Profit Margin23.80% Rel Volume1.76 Prev Close44.47
ShortableYes LT Debt/Eq0.50 EarningsJul 28 BMO Payout65.10% Avg Volume31.51M Price43.89
Recom2.60 SMA20-5.94% SMA50-2.03% SMA20011.53% Volume55,614,560 Change-1.30%
Jul-27-21Resumed Truist Buy $43
May-06-21Downgrade Mizuho Buy → Neutral $42
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Sep-18-21 05:25PM  
10:34AM  
07:30AM  
Sep-17-21 08:32PM  
08:00PM  
07:21PM  
06:05PM  
06:04PM  
05:19PM  
04:58PM  
04:41PM  
04:40PM  
04:30PM  
04:26PM  
03:59PM  
03:34PM  
03:23PM  
02:29PM  
02:09PM  
01:42PM  
12:49PM  
12:22PM  
12:10PM  
11:34AM  
09:53AM  
09:10AM  
08:14AM  
08:12AM  
07:58AM  
07:00AM  
06:49AM  
05:39AM  
Sep-16-21 07:01PM  
05:29PM  
05:19PM  
05:02PM  
04:15PM  
04:01PM  
03:08PM  
02:01PM  
12:10PM  
10:58AM  
10:55AM  
10:54AM  
10:36AM  
10:30AM  
10:00AM  
09:51AM  
07:49AM  
06:40AM  
06:00AM  
05:55AM  
04:39AM  
02:06AM  
Sep-15-21 11:15PM  
05:00PM  
04:34PM  
04:25PM  
04:07PM  
04:00PM  
04:00PM  
02:40PM  
02:30PM  
01:51PM  
01:20PM  
12:51PM  
11:59AM  
11:56AM  
11:33AM  
10:54AM  
09:47AM  
09:29AM  
08:57AM  
08:54AM  
08:43AM  
08:15AM  
08:11AM  
07:47AM  
07:46AM  
04:49AM  
04:01AM  
Sep-14-21 05:45PM  
04:07PM  
11:12AM  
10:00AM  
09:05AM  
07:55AM  
06:53AM  
06:17AM  
03:49AM  
Sep-13-21 10:37PM  
08:35PM  
05:31PM  
05:05PM  
04:45PM  
04:14PM  
04:04PM  
02:14PM  
02:07PM  
01:40PM  
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMICO JENNIFER B.SVP & ControllerAug 13Sale48.301,66180,2269,769Aug 16 08:12 PM
DAMICO JENNIFER B.SVP & ControllerJul 30Sale42.862,500107,15011,430Aug 02 07:02 PM
DAMICO JENNIFER B.SVP & ControllerMay 05Sale40.822,500102,05013,748May 07 04:10 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM